Drug Trial Radar · NCT07827599
A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
325
Planned (sponsor's estimate)
Start
Oct 16, 2026
Primary completion
Apr 30, 2027
Study completion Apr 30, 2027
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 5 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main purpose of the study is to evaluate the efficacy of a single dose of baloxavir marboxil compared with placebo in the PEP of influenza virus infection with respect to symptomatic, laboratory-confirmed influenza in participants who are household contacts (HHCs) of participants with influenza (index participants).
Conditions
- Influenza, Human
- Respiratory Tract Infections
- Post-exposure Prophylaxis
Interventions
Baloxavir marboxilDrug
Baloxavir marboxil will be administered to the HHCs as per the schedule specified in the protocol.
PlaceboDrug
Baloxavir marboxil matching placebo will be administered to the HHCs as per the schedule specified in the protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants who are Infected With Influenza Virus (Reverse Transcription - Polymerase Chain Reaction [RT-PCR] Positive), and Present With Fever and at Least one Respiratory SymptomTime frame: From Day 1 up to Day 10
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
The First People's Hospital of Changde
Changde, China · Recruiting
Peoples Hospital of Hunan Province
Changsha, China · Recruiting
Huizhou Central People's Hospital
Huizhou, China · Recruiting
Jiujiang No.1 People's Hospital
Jiujiang, China · Recruiting
Hebei Petro China Central Hospital
Langfang, China · Recruiting
Liuzhou People's Hospital
Liuzhou, China · Recruiting
Luoyang Central Hospital
Luoyang, China · Recruiting
Ningbo No.2 Hospital
Ningbo, China · Recruiting
Ningbo Women and Children's Hospital
Ningbo, China · Recruiting
Pingxiang People's Hospital
Pingxiang, China · Recruiting
Sanmenxia Central Hospital
Sanmenxia, China · Recruiting
The Third People's Hospital of Hainan Province
Sanya, China · Recruiting
Huashan Hospital Affiliated to Fudan University
Shanghai, China · Recruiting
The First Affiliated Hospital, Shaoyang University
Shaoyang, China · Recruiting
Shijiazhuang People's Hospital
Shijiazhuang, China · Recruiting
Weifang No.2 People's Hospital
Weifang, China · Recruiting
Xiamen Maternal and Child Health Hospital
Xiamen, China · Recruiting
Zhujiang Hospital, Southern Medical University
Guangzhou, Guangdong, China · Recruiting
Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China · Recruiting
Mianyang Central Hospital
Mianyang, Sichuan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.